Literature DB >> 20142222

Long-term clinical follow-up of drug-eluting stent restenosis treatment: retrospective analysis from two high volume catheterisation laboratories.

Francesco Tagliareni1, Alessio La Manna, Francesco Saia, Antonio Marzocchi, Corrado Tamburino.   

Abstract

AIMS: To evaluate clinical outcome of patients undergoing repeated percutaneous coronary intervention (PCI) for drug-eluting stent (DES) restenosis. METHODS AND
RESULTS: We identified 213 patients who underwent re-PCI for DES restenosis. The study population was divided in two groups according to the treatment strategy: 94 patients were treated with at least one repeat DES implantation (DES-sandwich group); 119 patients were treated with balloon angioplasty alone (BA group). Diffuse pattern of restenosis was more frequent in DES-sandwich group (34.0% vs. 17.6%; P=0.006). During a median follow-up of 20.2 months (interquartile range 13.7 to 30.1), the incidence of cardiac death was 6.5% in the DES-sandwich and 2.5% in the BA group (P=0.18), the incidence of myocardial infarction 6.5% and 0.8% (P=0.04), and the incidence of TLR 13% and 10.9% (P=0.63), respectively. After adjustment for angiographic characteristics, DES-sandwich strategy tended to be associated with a higher rate of myocardial infarction (OR 8.2, 95%CIs[0.9-69.6]; P=0.05). By multivariate analysis, early and diffuse pattern of restenosis were found as predictors of adverse outcome at follow-up (OR 4.7, 95%CI[2.2-9.6], P<0.001; OR 2.3, 95%CI[1.1-4.8], P=0.02, respectively).
CONCLUSIONS: A default strategy of repeat DES implantation does not seem to be advantageous and could be associated with a higher rate of myocardial infarction.

Entities:  

Mesh:

Year:  2010        PMID: 20142222     DOI: 10.4244/eijv5i6a116

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

1.  Hematopoietic stem cell capture and directional differentiation into vascular endothelial cells for metal stent-coated chitosan/hyaluronic acid loading CD133 antibody.

Authors:  Shixuan Zhang; Fan Zhang; Bo Feng; Qingyu Fan; Feng Yang; Debin Shang; Jinghan Sui; Hong Zhao
Journal:  Tissue Eng Part A       Date:  2014-12-23       Impact factor: 3.845

Review 2.  Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.

Authors:  Daniele Giacoppo; Giuseppe Gargiulo; Patrizia Aruta; Piera Capranzano; Corrado Tamburino; Davide Capodanno
Journal:  BMJ       Date:  2015-11-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.